2m 2m 2m 2m 2m 2m 2m
Neogenomics (NEO)
NASDAQ
$10.00-$0.12 (-1.19%)
Price as of Jun 03, 2026 7:33 PM EDT- $1.4BMarket Cap
- 35.29%1-Year Change
- Diagnostics & ResearchIndustry
Neogenomics (NEO)
$10.00-$0.12 (-1.19%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 727.3M +10.11% | 660.6M +11.65% | 591.6M +16.07% | 509.7M +5.24% | |
Cost of Revenue | 413.0M +11.49% | 370.5M +6.75% | 347.0M +7.83% | 321.8M +8.26% | |
Gross Profit | 314.3M +8.34% | 290.1M +18.60% | 244.6M +30.18% | 187.9M +0.45% | |
Sales and Marketing Expense | 92.0M +8.69% | 84.7M +19.49% | 70.8M +5.23% | 67.3M +7.55% | |
Research and Development Expense | -37.1M +18.99% | -31.2M +14.10% | -27.3M -9.95% | -30.3M +38.65% | |
Depreciation and Amortization Expense | 31.8M -5.06% | 33.4M -4.80% | 35.1M +3.16% | 34.1M +47.06% | |
Total Operating Expenses | 430.2M +12.55% | 382.2M +8.48% | 352.3M +1.97% | 345.5M +12.98% | |
Operating Profit | -115.9M +25.81% | -92.1M -14.51% | -107.7M -31.65% | -157.6M +32.73% | |
Interest Income | 9.1M -50.78% | 18.4M +9.02% | 16.9M N/A | N/A N/A | |
Interest Expense | N/A N/A | N/A N/A | -6.9M +358.63% | -1.5M -70.37% | |
Interest Income and Expense and Net | 9.1M -50.78% | 18.4M +84.36% | 10.0M +763.68% | -1.5M -70.37% | |
Total Nonoperating Income and Expense | 296,000 +178.10% | -379,000 -158.85% | 644,000 +402.35% | -213,000 -57.31% | |
Income before Taxes | -110.3M +36.68% | -80.7M -16.91% | -97.1M -39.06% | -159.3M +957.00% | |
Income Taxes | -2.2M +15.08% | -1.9M -78.65% | -9.1M -39.51% | -15.1M +124.32% | |
Extraordinary Items | 15.9M N/A | N/A N/A | N/A N/A | 718,000 N/A | |
Net Income | -108.0M +37.22% | -78.7M -10.51% | -88.0M -39.02% | -144.3M +1,628.17% | |
Net Income from Continuing Operations Applicable to Common | -110.3M +36.68% | -80.7M -16.91% | -97.1M -39.06% | -159.3M +957.00% | |
Basic EPS and Net Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Diluted EPS and Net Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Basic Weighted Average Shares | 128.1M +1.14% | 126.7M +0.92% | 125.5M +1.03% | 124.2M +3.55% | |
Diluted Weighted Average Shares | 128.1M +1.14% | 126.7M +0.92% | 125.5M +1.03% | 124.2M +3.55% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 159.6M -56.51% | 367.0M +7.16% | 342.5M +30.13% | 263.2M -16.93% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 159.6M -56.51% | 367.0M +7.16% | 342.5M +30.13% | 263.2M -48.94% | |
Total Current Assets | 376.3M -36.87% | 596.0M -0.13% | 596.8M -1.40% | 605.3M -11.18% | |
Accumulated Depreciation | 209.1M +10.04% | 190.0M +20.09% | 158.2M +19.92% | 131.9M +19.99% | |
Property and Plant and Equipment and Net | 84.8M -9.85% | 94.1M +2.27% | 92.0M -10.23% | 102.5M -6.36% | |
Total Long-Term Assets | 983.5M -5.61% | 1.0B -3.91% | 1.1B -4.44% | 1.1B -4.50% | |
Total Assets | 1.4B -16.98% | 1.6B -2.57% | 1.7B -3.38% | 1.7B -6.94% | |
Income Taxes Payable | 18.2M -15.30% | 21.5M -11.43% | 24.3M -30.12% | 34.8M -37.36% | |
Total Short-Term Debt | 0 -100.00% | 200.8M -62.69% | 538.2M -1.39% | 545.8M +0.12% | |
Total Current Liabilities | 88.3M -70.69% | 301.2M +212.80% | 96.3M +7.09% | 89.9M +3.10% | |
Total Long-Term Debt | 341.9M +0.45% | 340.3M -36.76% | 538.2M +0.54% | 535.3M +0.53% | |
Total Long-Term Liabilities | 435.0M +0.12% | 434.5M -32.47% | 643.4M -1.33% | 652.1M -3.29% | |
Total Liabilities | 523.3M -28.87% | 735.7M -0.54% | 739.7M -0.31% | 742.0M -2.56% | |
Retained Earnings | -433.8M +33.16% | -325.8M +31.87% | -247.1M +55.30% | -159.1M +972.23% | |
Total Stockholders Equity | 836.6M -7.29% | 902.3M -4.16% | 941.5M -5.66% | 998.0M -9.95% | |
Total Shares Outstanding | 128.1M +0.61% | 127.4M +0.36% | 126.9M +2.26% | 124.1M +10.74% | |
Cash Flow | |||||
Cash from Operating Activities | 5.2M -25.53% | 7.0M +459.60% | -2.0M -97.04% | -66.0M +146.95% | |
Capital Expenditures | 27.0M -34.22% | 41.1M +42.81% | 28.8M -6.92% | 30.9M -51.84% | |
Cash from Investing Activities | -12.3M -195.96% | 12.9M -83.24% | 76.7M +14,736.94% | 517,000 +100.08% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | -200.3M -4,410.98% | 4.6M +2.02% | 4.6M -61.50% | 11.8M -98.37% | |
Financials Ratio | |||||
Gross Margin | 43.21% -1.61% | 43.92% +6.23% | 41.34% +12.16% | 36.86% -4.56% | |
Operating Margin | -15.93% +14.26% | -13.94% -23.43% | -18.21% -41.11% | -30.92% +26.12% | |
Return on Assets | -7.21% +51.93% | -4.74% -7.76% | -5.14% -35.66% | -7.99% +1,268.28% | |
Return on Equity | -12.42% +45.50% | -8.54% -5.86% | -9.07% -33.77% | -13.70% +1,379.00% | |
Revenue Growth | 10.11% -13.24% | 11.65% -27.51% | 16.07% +206.44% | 5.24% -41.56% | |
Current Ratio | 4.26 +115.39% | 1.98 -68.07% | 6.20 -7.92% | 6.73 -13.85% | |
Cash Ratio | 1.81 +48.38% | 1.22 -65.74% | 3.56 +21.52% | 2.93 -19.43% | |
Debt-to-Equity Ratio | 0.41 -31.87% | 0.60 -47.54% | 1.14 +5.54% | 1.08 +11.41% | |
Debt-to-Assets Ratio | 0.25 -23.89% | 0.33 -48.41% | 0.64 +3.04% | 0.62 +7.81% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow